SEMA3A and amyotrophic lateral sclerosis: We detected significantly lower levels of miR-494-3p (p = .02, Two-tailed t-test), while SEMA3A did not show a significant increase as predicted in the cortico-spinal tract when comparing 3 sporadic ALS (sALS) patients to 3 non-ALS controls (Fig. 4e, f).